Vishwas Setia - 25 Oct 2025 Form 3 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Role: Chief Financial Officer
Signature: /s/ Kristopher L. Hanson, Attorney-in-Fact
Issuer symbol: MPLT
Transactions as of: 25 Oct 2025
Net transactions value: $0
Form type: 3
Filing time: 27 Oct 2025, 16:42:34 UTC
Next filing: 28 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Setia Vishwas	Chief Financial Officer	C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY	/s/ Kristopher L. Hanson, Attorney-in-Fact	27 Oct 2025	0002021256

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MPLT	Voting Common Stock						377,834	25 Oct 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Of the RSUs, (i) as to 129,321 RSUs, 56,578 vested in connection with the Issuer's IPO and the remainder will vest in quarterly installments through January 1, 2028; and (ii) as to 248,513 RSUs, 14/48ths will vest on July 1, 2026 and the remainder will vest in 12 quarterly installments thereafter. With respect to all RSUs, vesting is subject to the Reporting Person's continued service through each vesting date.
F2	Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.

Content

Of the RSUs, (i) as to 129,321 RSUs, 56,578 vested in connection with the Issuer's IPO and the remainder will vest in quarterly installments through January 1, 2028; and (ii) as to 248,513 RSUs, 14/48ths will vest on July 1, 2026 and the remainder will vest in 12 quarterly installments thereafter. With respect to all RSUs, vesting is subject to the Reporting Person's continued service through each vesting date.

Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.